We evaluated the prevalence, image appearance, associated cardiovascular anomalies, and surgical outcomes of left pulmonary artery sling (LPAS) using cardiovascular computed tomography angiography (CCTA). A retrospective search of patients from our database between October 2007 and December 2014 identified 52,200 patients with congenital heart diseases (CHD) referred for CCTA, echocardiography, or magnetic resonance imaging. Clinical information, CCTA findings, associated cardiovascular anomalies, and surgical outcomes were analyzed. We showed a hospital-based prevalence of 71 patients with LPAS (0.14%, 71/52,200) among CHD patients. Of these, 47 patients with CCTA examinations were assessed further. Most patients (40/47, 85%) had associated cardiovascular anomalies, of which ventricular septal defects (22/47, 47%), atrial septal defects (20/47, 43%), patent ductus arteriosus (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the right pulmonary artery (ABRPA) (14/47, 30%) were most commonly identified. In total, 28 patients underwent LPA reanastomosis and/or tracheoplasty in our center, and 5 died. LPAS had a hospital-based prevalence of 0.14% among CHD patients. ABRPA is not uncommon and must be recognized. CCTA is a feasible method for demonstrating LPAS and its associated cardiovascular anomalies for an optimal pre-operative assessment of LPAS.
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Cardiovascular computed tomography angiography (CCTA) is accepted as one of the imaging techniques for the evaluation of congenital heart disease (CHD) and is particularly beneficial for depicting both cardiovascular and tracheobronchial anomalies for surgical planning [4] [5] [6] . Previous studies have reported that tracheobronchial anomalies have a greater impact on the patients' prognosis compared with cardiac defects 7, 8 . Minor cardiovascular anomalies, such as abnormal branching of the right pulmonary artery (ABRPA), can go unnoticed by both radiologists and cardiologists, and their clinical importance was also been inadequately emphasized in prior reports on LPAS. However, recognition of such imaging findings is critical for safe surgical separation of the anomalous pulmonary arteries when treating patients with LPAS. Thus, we conducted this study based on the CCTA manifestations of LPAS to analyze the prevalence of associated cardiovascular anomalies differences between the types of LPAS, and surgical outcomes.
Materials and Methods
Patient selection and clinical information. In this institutional review board approved study (Research Ethics Committee, Guangdong General Hospital, Guangdong Academy of Medical Sciences: No. GDREC2014283H), we conducted a retrospective search for patients with LPAS from our departmental database, which consists of all patients referred for CCTA, echocardiography, or magnetic resonance imaging (MRI) due to CHD. Patients with CCTA examinations were recruited for further studies. All methods were performed in accordance with the relevant guidelines and regulations, and the institutional review board waived the need for informed consent. We recorded and summarized clinical information, including sex, age, presenting symptoms, preoperative ventilation duration, imaging modalities, surgical treatment and outcomes of the patients with LPAS.
Imaging protocols and post-processing methods. Because of the long study period of 7 years, the patients had undergone two different CCTA scanning protocols using two different CT scanners, as detailed in a previous report 9 .
Clinical information, image analysis and estimated radiation dosage. The prevalence of LPAS was calculated as the number of patients with LPAS among all patients with CHD evaluated by CCTA, echocardiography or MRI during the same period at our tertiary center. Transthoracic echocardiography (TTE) images were reviewed by a cardiologist, while the CCTA images were interpreted by two radiologists in consensus from our group. The classification of LPAS was according to the method proposed by Wells et al. 2 . According to the differences in tracheobronchial anomalies, LPAS is divided into two main types based on the thoracic level of the carina (type 1: T4-5, type 2: T6-7) and into two subtypes based on the presence or absence of a right upper lobe bronchus. The associated congenital cardiovascular anomalies were analyzed using the CCTA images.
The estimated effective dosages in millisieverts (mSv) for these patients were calculated based on the patients' age 10 .
Statistical analysis. Descriptive statistics were used to describe the frequencies (percentage) of each anomaly. The χ 2 test or Fisher's exact test was used to compare the presence or absence of the associated cardiovascular anomalies between the two types of LPAS, where appropriate. A p-value of < 0.05 was considered to indicate statistical significance. Statistical analyses were performed using the SPSS software (ver. 17; SPSS Inc., Chicago, IL, USA). Table 1 . The median age of the patients was 5 months old (range, 1 day to 60 months). TTE was performed in 40 of the 47 patients with LPAS, while 13 of these patients were diagnosed improperly. Among these 13 cases, 10 cases were inadequately seen (10/40, 25%). Other than LPAS, these 10 patients also had other coexisting findings, comprising of ASD and PLSVC in one patient; PDA in the second patient; VSD, ASD and PAH in the third patient; PFO in the fourth patient; ASD in the fifth patient; DORV, ASD, VSD and PS in the sixth patient; TGA, RAA and PS in the seventh patient; PDA and ASD in the eighth patient; TOF in the ninth patient; VSD and ASD in the tenth patient. Two cases were misdiagnosed as normal (2/40, 5%), and one case misdiagnosed with LPA hypoplasia (1/40, 3%)
Clinical information Total
Types of tracheobronchial abnormalities based on CCTA and estimated radiation exposure.
According to method of Wells classification for LPAS [2] , there were 20 patients (20/47, 43%) with type 1 (type 1A: 14 patients and type 1B: 6 patients, Figs 1 and 2) and 27 patients (27/47, 57%) with type 2 manifestations (type 2A: 14 patients and type 2B: 13 patients, Figs 3 and 4) in our series. The median and range values of the estimated effective radiation dosages using the 64-and 256-slice CT scanners were 5.09 mSv (3.42 mSv-7.67 mSv) and 1.14 mSv (0.42 mSv-2.77 mSv) in their respectively age groups.
Associated congenital cardiovascular anomalies based on CCTA. Of the patients with LPAS in our series, 85% (40/47) had other associated congenital cardiovascular anomalies. The distribution of associated CHD is listed in Table 2 . Ventricular septal defect (VSD; 22/47, 47%) was the most commonly found associated anomaly in LPAS patients, followed by atrial septal defect (ASD; 20/47, 43%), patent ductus arteriosus (PDA; 16/47, 34%, including 5 neonates), persistent left superior vena cava (PLSVC; 14/47, 30%), ABRPA (14/47, 30%), coarctation of the aorta (CoA; 6/47, 13%), and abnormalities of aortic arch branching (6/47, 13%). Most of the associated anomalies were seen more with type 2 than type 1 LPAS, but there was no significant difference, with the exception of ABRPA (2 cases with type 1 vs. 12 cases with type 2, p = 0.011).
Abnormalities of aortic arch branching, including aberrant right subclavian artery (3 cases, 6%), aberrant left subclavian artery (1 case), common trunk with left innominate artery and left common carotid artery (1 case), and left vertebral artery originating from the aortic arch (1 case), seemed to be more common in patients with type 2 than type 1 LPAS (Table 2) . Another five associated CHD were also found: one involved the anomalous origin of the right coronary artery and partial anomalous pulmonary venous connection (PAPVC), one involved the transposition of great arteries (TGA) associated with the right arch and right descending aorta (Fig. 1) , one involved the double-outlet right ventricle (DORV) associated with pulmonary stenosis, and one involved the tetralogy of Fallot (TOF).
Abnormal branching of the right pulmonary artery. We reviewed all of the proximal branches of the RPA on CCTA images, and the results are summarized in Table 3 . The results showed that the right upper pulmonary artery (RUPA) could originate from the RPA, the common orifice just between the LPA and RPA and even the LPA (35/47, 74%, 2/47, 4%, and 10/47, 21% respectively, Fig. 5B-D) . There were more patients with type 2 than type 1 LPAS (8 and 2 patients, respectively) with an anomalous origin of the RUPA from LPA, but the difference was not statistically significant, probably due to the small sample numbers.
In two other ABPRA cases, one showed an anomalous origin of the right middle pulmonary artery (RMPA) (Fig. 5e ) from the LPA, and the other showed an anomalous origin of the right lower pulmonary artery (RLPA) from the common orifice of the LPA and RPA (Fig. 5f ).
Surgical treatment, clinical outcomes and follow-up. In total 28 (28/47, 60%) patients underwent surgery to correct the cardiovascular anomalies or tracheal abnormalities in our series, including 13 type 1 and 15 type 2 patients (46% vs 54%). LPA reimplantation was performed in 27 patients (27/28), including two patients with accompanying tracheoplasties (one patch augmentation and one sliding tracheoplasty), while one patient had only a sliding tracheoplasty. These three patients receiving tracheal surgeries were all type 2 cases. Other associated procedures (such as correct or palliative operations) were also performed for these patients to correct other associated cardiovascular anomalies, including ASD closure, VSD repair, PDA ligation, right ventricular outflow tract patch expansion. pulmonary artery (PA) banding, and a bidirectional Glenn shunt. Among the five deaths, three were early deaths due to severe hypoxic ischemic encephalopathy (1 patient) and aggravation of preexisting respiratory failure (2 patients), and the other two deaths occurred later due to airway obstruction by repetitive granulation tissue growing after the tracheoplasty. In the 23 living patients, including one patient who underwent tracheal surgery, their respiratory symptoms improved over an average of 20 days of postoperative hospitalization, and the patients were well at 1-year follow-up visit.
Discussion
Yu et al. 11 evaluated the prevalence of LPAS in a large-scale screening study using 2D echocardiography, and found a prevalence of 59 per million school-aged children. Our cohort complemented the study by Yu et al., showing a hospital-based prevalence of 0.14% (71/52,200) among patients with CHD.
Gikonyo et al. 3 reviewed the clinical symptoms of LPAS and reported that LPAS usually causes airway obstruction before 1 year of age in ~90% of cases; however, 14 (12%) of the 130 patients surveyed were asymptomatic. Our cohort showed similar results in that 10% (5/47) of patients were asymptomatic, while 89% (42/47) had associated clinical manifestations, with an median onset age of 5 months (79% presenting with shortness of breath, and 36% required preoperation ventilation; dysphagia occurred in 23%, Table 1 ).
According to the classification method for the tracheobronchial tree proposed by Wells et al. 2 , tracheal bifurcation of type 1 LPAS is located at the T4-5 level just above the carina, while type 2 is at the T6-7 level. Type 2 LPAS is associated with left intermediate bronchus and bridging bronchus and the location at T6-7 is more commonly associated with longer tracheobronchial stenosis which increases respiratory difficulties.
The proportion of type 1 LPAS in our cohort (43%, 20/47) is similar to that reported by Zhong et al. (48%, 13/27) 12 using the same classification scheme. Type 1A refers to a normal tracheobronchial branch pattern and was seen in 30% (14/47) of patients in our cohort, also similar to the results of Zhong et al. (8/27, 30%) . Other types such as type 1B, 2A and 2B are abnormal tracheobronchial branch patterns. Among these, type 1B is similar to type 1A but has a true right tracheal bronchus or tracheal diverticulum. Type 2 LPAS was more common; our results were consistent with the results of Wells et al. and Lee et al. 2, 13 . We also observed more operative mortalities among type 2 versus type 1 due to poor preoperative airway conditions (4 of 5 deaths were type 2 LPAS in our series).
Our study showed that VSD (22/47, 47%), ASD (20/47, 43%), PDA (16/47, 34%, including 5 neonates, all without prostaglandin therapy) and PLSVC (14/47, 30%) were common findings in LPAS patients. These results are much higher than those reported in a case review by Gikonyo et al., which showed remarkably lower proportions of VSD (12/93, 13%), ASD (9/93, 10%), PDA (4/93, 4%), and PLSVC (8/93, 9%) 3 . However, our results were more similar to the CCTA study of Chen et al. from Taiwan: VSD (4/18, 22%), ASD (6/18, 33%), PDA (7/18, 39%), and PLSVC (4/18, 22%) 14 .
Our results showed that ABRPA is not an uncommon condition in patients with LPAS (14/47, 30%). However, to our knowledge, a RUPA anomaly originating from the LPA has only been reported in one case report 15 from 1977, and no case of a right middle or lower pulmonary artery (RMPA) anomaly originating from LPA has been reported in the English language literature. In addition to the lack of emphasis in prior reports, ABRPA may be overlooked by both radiologists and cardiac surgeons. When ABRPA is unrecognized or misdiagnosed as a part of the RPA during surgery, cardiac surgeons may accidentally injure the anomalous origin of the ABRPA, increasing the risk of complications (such as major intraoperative blood loss) or the duration of hospitalization. Thus, pre-operative confirmation of the presence of ABRPA is important when considering surgical treatment of LPAS. For the patients in whom surgery was not performed, CCTA can be an alternative reference standard for the diagnosis of LPAS.
In the present study, complex cardiovascular anomalies were not common in patients with LPAS. Only a few case reports have focused on LPAS with TOF, DORV, or PAPVC 3, [16] [17] [18] . Consistent with previous reports, our study showed one case each with PAPVC and TOF. To our knowledge, the combined finding of TGA with LPAS has not been reported before. The only case of LPAS with TGA in our series was also associated with complex cardiovascular anomalies, including right aortic arch, ASD, VSD and PDA. This patient subsequently underwent LPA reimplantation, PDA suture and PA banding. Reimplantation of the left pulmonary artery with or without tracheoplasty and simultaneous surgical correction of cardiac defects were performed safely in most of the LPAS patients, with a survival rate of 82% (23/28), mean hospitalization duration of 20 days, and good 1-year follow-up results.
The rate of postoperative mortality in our study was 17.9% (5/28), which is in consistent with other reports on LPAS patients from the past two decades, in which the rates ranged from 11% to 45% 12, 14, [19] [20] [21] . Yong et al. 21 showed a descending trend for the postoperative mortality every ten years from 1984 to 2011, with an average of ~14.3%. Yong et al. also explained that the mortalities were related to the need for tracheal surgery, while those who did not require tracheal surgery had excellent outcomes.
Limitation
Our study was limited by its retrospective nature and data collection from a single tertiary medical center. Further large-scale prospective studies may allow us to further clarify the differences among the results from our cohort and other prior studies. In addition, although all patients had typical imaging presentations of LPAS on CCTA, only 60% of patients were confirmed by surgery. The patients receiving only echocardiography were lost to follow-up after the initial diagnosis, which limited the total number of LPAS patients to 47 for further analysis. Future studies involving larger cohorts of patients may further confirm the results of our study. For the patients who did not undergo surgery, the diagnosis of LPAS could not be confirmed by surgical findings, despite typical imaging findings on CCTA. Furthermore, LPAS remains a rare congenital anomaly, and due to the high proportion of patients with tracheobronchial anomalies, further studies focusing on characterizing the CCTA findings of the tracheobronchial entities may be beneficial. Finally, the diagnosis of ABRPA is often overlooked, and follow-up study focusing on the diagnosis of ABRPA and the feasibility of CCTA in the pre-operative diagnosis of ABRPA from interobserver comparison may be beneficial in understanding the advantage of CCTA in assisting the diagnosis of ABRPA.
Conclusions
LPAS had a hospital-based prevalence of 0.14% among patients with congenital heart diseases. The results in this study showed ABRPA is not uncommon and must be recognized. CCTA is an excellent tool for demonstrating LPAS and its associated cardiovascular anomalies, which is crucial information for an optimal preoperative assessment of LPAS.
